In addition, BRCA1/2-deficient cancer cells may develop PARPi resistance by protecting their replication forks; they achieve this by blocking the recruitment of nucleases, MRE11 or MUS81, to the stalled fork, thereby resulting in fork protection [267,268]. The gene discussed is BRCA1; the disease is cancer.